Dementias Terminated Phase 1 Trials for MK-0249 (DB11910)

Also known as: Dementia / Dementia NOS / Amentia

IndicationStatusPhase
DBCOND0060453 (Dementias)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00874939A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)Treatment